PMCPA Case
| Case number | AUTH/2753/3/15 |
| Company | ViiV Healthcare UK Ltd |
| Product | Triumeq (dolutegravir/abacavir/lamivudine) |
| Medium | Printed journal advertising (double-page spread + belly band wrapper) |
| Publication | International Journal of STD and Aids (February 2015 issue) |
| Issue | Exceeded maximum of two pages of advertising for a particular product in one journal issue |
| Applicable Code year | 2014 |
| Breach clauses | Clause 6.3 |
| Complaint received | 20 March 2015 |
| Case completed | 13 April 2015 |
| Appeal | No appeal |
| Sanctions | Undertaking received |
| Stated cause | Scheduling/administration error involving publisher systems following knock-on changes from artwork delays; publisher accepted responsibility, company accepted overall responsibility |
Download the full case report (PDF)
Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory
Got a question about this case?
Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.
⭐ Business Intelligence Access
See the full compliance picture for every pharma company
291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.
One real case. One key lesson. Every week — free.